Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Trade Groups Back Matrixx On AER Disclosure In Supreme Court Case

This article was originally published in The Tan Sheet

Executive Summary

Blanket disclosure of all adverse event reports would be "detrimental to investors and consumers," trade groups say in a brief supporting Matrixx Initiatives in its dispute with shareholders

You may also be interested in...



Supreme Court's Matrixx Decision Expands Firms' Disclosure Burden

The Supreme Court's decision in a complaint shareholders brought against Matrixx Initiatives lowers the threshold for when firms need to disclose information, but also aims to prevent an "avalanche of trivial information."

Supreme Court's Matrixx Decision Expands Firms' Disclosure Burden

The Supreme Court's decision in a complaint shareholders brought against Matrixx Initiatives lowers the threshold for when firms need to disclose information, but also aims to prevent an "avalanche of trivial information."

Supreme Court's Matrixx Decision Expands Firms' Disclosure Burden

The Supreme Court's decision in a complaint shareholders brought against Matrixx Initiatives lowers the threshold for when firms need to disclose information, but also aims to prevent an "avalanche of trivial information."

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104480

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel